Skip to Main Content
Outsourcing Facilities
Association
Apply
Outsourcing Facilities Association

Outsourcing FacilitiesSupply Drugsin Shortage

Search the listing of 503B outsourcing facilities that supply drugs on FDA’s drug shortage list, then contact the facility directly.

Drugs listed
34, of which 29 are on FDA’s shortage list
Facilities
29 registered outsourcing facilities
Last updated
12 September, on OFA’s previous site

Which outsourcing facility supplies the drug you cannot get?

  1. Albuterol Sulfate Inhalational Solution

    On FDA’s shortage list

    1 facility

  2. Atropine sulfate

    On FDA’s shortage list

    5 facilities

  3. Bupivacaine hydrochloride

    On FDA’s shortage list

    3 facilities

  4. Cisatracurium besylate

    Not marked as on FDA’s shortage list

    1 facility

  5. Cyclopentolate Ophthalmic Solution

    On FDA’s shortage list

    1 facility

  6. Desmopressin acetate nasal spray

    On FDA’s shortage list

    1 facility

  7. Dexamethasone sodium phosphate

    On FDA’s shortage list

    4 facilities

  8. Dexmedetomidine hydrochloride

    On FDA’s shortage list

    3 facilities

  9. Dextrose 50%

    On FDA’s shortage list

    1 facility

  10. Epinephrine

    On FDA’s shortage list

    5 facilities

  11. Epinephrine hydrochloride

    On FDA’s shortage list

    1 facility

  12. Fentanyl citrate

    On FDA’s shortage list

    15 facilities

  13. Furosemide

    On FDA’s shortage list

    1 facility

  14. Hydromorphone hydrochloride

    On FDA’s shortage list

    12 facilities

  15. Ibuprofen suspension

    Not marked as on FDA’s shortage list

    1 facility

    FDA Guidance on Compounding Ibuprofen Suspension

  16. Ketamine

    On FDA’s shortage list

    1 facility

  17. Ketamine hydrochloride

    On FDA’s shortage list

    9 facilities

  18. Ketamine Injection

    On FDA’s shortage list

    1 facility

  19. Ketorolac tromethamine

    On FDA’s shortage list

    1 facility

  20. Lidocaine hydrochloride

    On FDA’s shortage list

    4 facilities

  21. Lorazepam

    On FDA’s shortage list

    1 facility

  22. Midazolam hydrochloride

    On FDA’s shortage list

    11 facilities

  23. Morphine sulfate

    On FDA’s shortage list

    9 facilities

  24. Norepinephrine bitartrate

    Not marked as on FDA’s shortage list

    9 facilities

  25. Ondansetron hydrochloride

    On FDA’s shortage list

    1 facility

  26. Rocuronium bromide

    Not marked as on FDA’s shortage list

    8 facilities

  27. Ropivacaine hydrochloride

    On FDA’s shortage list

    4 facilities

  28. Sodium bicarbonate

    On FDA’s shortage list

    1 facility

  29. Sodium chloride

    On FDA’s shortage list

    1 facility

  30. Sodium chloride 0.9%

    On FDA’s shortage list

    1 facility

  31. Sodium chloride 23.4%

    On FDA’s shortage list

    2 facilities

  32. Triamcinolone acetonide

    On FDA’s shortage list

    1 facility

  33. Vancomycin hydrochloride

    Not marked as on FDA’s shortage list

    7 facilities

  34. Vecuronium bromide

    On FDA’s shortage list

    1 facility

About this listing

  • Not every 503B listed is a member of OFA.
  • The information comes from the publicly available FDA website and the six-month product reports FDA publishes. 503Bs developing formulations that may be released soon may also be listed.
  • OFA makes no representation about the quantity or nature of any product listed. OFA has no pricing data. Please contact the 503B directly for a full product catalog.

Official sources

Are you a 503B?

Facilities may submit updates to their own listing at any time.

Submit a listing update

Notice to Hospitals

Cannot obtain FDA-approved drugs? Outsourcing facilities are subject to more quality standards than other compounders and supply drugs in shortage.

Hospitals that cannot obtain adequate supplies of FDA-approved drugs, and are considering compounded drugs for their hospitalized patients, should first contact outsourcing facilities. They are subject to more robust quality standards than state-licensed pharmacies or federal facilities that do not register with FDA as outsourcing facilities.

Close view of an IV bag and drip chamber in a hospital room.

Report a Shortage of FDA-Approved Tirzepatide

Tell OFA if you have had trouble filling a prescription for FDA-approved tirzepatide.

A Unified Voice for the Facilities That Supply These Drugs

OFA represents FDA-registered 503B outsourcing facilities at FDA, in Congress and in the courts.